A Phase 2 Clinical Trial Examining the Effects on Osteoarthritic Knee Pain of CGS-200-1, CGS-200-5 and Vehicle Control
Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-blind clinical trial to examine the comparative
effects on OAKP of CGS-200-1 (1% Capsaicin content) (N=40), CGS-200-5 (5% Capsaicin content)
(N=40), and CGS-200 Vehicle (no Capsaicin) (N=40) in subjects with OA of the knees according
to the 1986 American College of Rheumatology (ACR) criteria. Assigned doses will be applied
at the clinic for 60 minutes on each of four consecutive days.